Boston Scientific Corp.

NYSE:BSX  
42.33
+0.57 (+1.36%)
Other Pre-Announcement

Boston Scientific Posts Q2 EPS Of $0.17

Published: 07/27/2022 11:04 GMT
Boston Scientific Corp. (BSX) - Boston Scientific Announces Results for Second Quarter 2022.
Q2 GAAP Earnings per Share $0.17.
Q2 Sales Rose 5.4 Percent to $3.244 Billion.
Q2 Earnings per Share View $0.42, Revenue View $3.22 Billion -- Refinitiv Ibes Data (analyst estimates).
Boston Scientific - Estimates Net Sales Growth for FY 2022, Versus Prior Year Period, to Be in a Range of About 6.5 to 7.5 Percent on a Reported Basis.
Now Estimates EPS on a GAAP Basis in a Range of $0.69 to $0.76 for FY.
Estimates Adjusted Eps, Excluding Certain Charges (credits), of $1.74 to $1.77 for FY.
Qtrly Cardiovascular Segment Sales $1,996 Million Versus $1,883 Million.
Boston Scientific - Estimates Net Sales Growth for Q3 , Versus Prior Year Period, to Be in a Range of Approximately 6 to 8 Percent on a Reported Basis.
Q2 Earnings per Share View $0.42, Revenue View $3.22 Billion -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share View $0.45, Revenue View $3.20 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $1.76, Revenue View $12.82 Billion -- Refinitiv Ibes Data (analyst estimates).
Boston Scientific -sees Q3 EPS on a GAAP Basis in a Range of $0.20 to $0.24 and Adjusted Eps, Excluding Certain Charges (credits), of $0.43 to $0.45.